US pharma major Bristol Myers Squibb has announced the appointment of Harald Hampel as senior vice president, worldwide head ...

US immunotherapy company ImmunityBio has announced that the Saudi Food and Drug Authority (SFDA) has granted accelerated ...

As leaders gather in Davos, it can feel like a lifetime since three feet of distance defined daily life. Yet it was only six ...

Maziar Mike Doustdar, the new president and chief executive of Danish pharma major Novo Nordisk, had the chance to set out ...

US commercial-stage biopharma Pelthos Therapeutics (NYSE: PTHS) has secured a senior secured term loan facility of up to $50 ...

US President Donald Trump’s recent warning of a 25% tariff on countries trading with Iran introduces fresh uncertainty for ...

Of the billions that have been made and lost by investors in big pharma in the last two or three years, a significant chunk ...

US pharma major Merck (NYSE: MRK) is trying to make its looming Keytruda (pembrolizumab) patent hill look more like a speed ...

Cambridge, USA-based clinical-stage biotechnology company Caldera Therapeutics, which is developing the first-in-class ...

Spanish dermatology specialist Almirall (BME: ALM) is using its appearance at the 44th JP Morgan Healthcare Conference in San ...

Switzerland-based Sandoz, a global leader in affordable medicines, today confirmed that the European Commission has granted ...

The Danish company Novo Nordisk is trying to stop exports of the Russian generic of Ozempic (semaglutide), which has been ...